A method for promoting production of phenoxazine-1-carboxylic acid by limiting a competing pathway for phenoxazine synthesis
By using genetic engineering to restrict the siderophore and salicylic acid synthesis pathways of *Pseudomonas aeruginosa*, engineered strains QPCA-8 and QPCA-9 were constructed. This solved the problem of low efficiency in the production of phenazine-1-carboxylic acid by *Pseudomonas aeruginosa*, significantly increasing the yield of phenazine-1-carboxylic acid and reducing production costs.
Patent Information
- Application Number
- CN202410174661.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-07
- Publication Date
- 2026-06-26
- Estimated Expiration
- 2044-02-07
AI Technical Summary
The current efficiency of Pseudomonas aeruginosa in producing phenazine-1-carboxylic acid is low, resulting in high production costs and limiting its widespread application in biopesticides.
By restricting the siderophore and salicylic acid synthesis pathway of *Pseudomonas aeruginosa*, and by using genetic engineering to knock out the ycaC and/or pabC genes, engineered strains QPCA-8 and QPCA-9 were constructed. This guided more carbon flux into the phenazine synthesis pathway, thereby improving the production efficiency of phenazine-1-carboxylic acid.
The production efficiency of phenazine-1-carboxylic acid was significantly improved, with the yield of strain QPCA-8 increasing to 8914 mg/L and the yield of QPCA-9 further increasing to 9948 mg/L, while reducing production costs.